Clinical Trials in Chicago

Showing 12021-12040 of 17,609 trials

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

NCT00430638

This 16 week study will examine the ability of olmesartan medoxomil to lower the blood pressure of patients with moderate to severe high blood pressure in comparison to placebo. The medication being tested has been approved by the FDA for the treatment of high blood pressure.

Hypertension

Daiichi Sankyo278 participantsStarted Dec 2006

Birmingham, Alabama, United States • Mobile, Alabama, United States • Muscle Shoals, Alabama, United States +26 more locations

COMPLETEDPhase 22.2 miles

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

NCT00175825

This trial will evaluate the efficacy and safety of brivaracetam (at doses of 5, 20 and 50 mg/day in twice a day administration) as add-on therapy in subjects with focal epilepsy.

Epilepsy

UCB Pharma210 participantsStarted Nov 2005

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Fresno, California, United States +39 more locations

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Find Trials by Condition in Chicago

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Medical Therapy of Prostatic Symptoms

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B

A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer

Phase II Combination Steroid and Anti-VEGF for Persistent DME

Assessing Fitting Guides in Alcon Multifocal Contact Lenses

Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A

Multicenter Continuous Peripheral Nerve Block Surveillance Study

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

Gastric Electrical Stimulation (GES) for the Treatment of Obesity

Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)

PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation